Summary of Expertise, Experience and Affiliations and Interests for the Scientific Advisory Panel on Opioids (SAP-Opioids)

Purpose of the Summary

The following summarizes the information about expertise or experience, affiliations and interests relevant to the Scientific Advisory Panel on Opioids (SAP-Opioids) mandate declared by panel members. Health Canada considers these declarations as part of the selection process. The Health Products and Food Branch has made this summary available as part of its commitment to be transparent about the membership of its advisory bodies.

Assessment of affiliations and interests prior to each meeting

Prior to the panel meeting, Health Canada assesses members' affiliations and interests, including direct financial interests, as they may apply to agenda items for discussion. Depending on the nature of the member's affiliations or interests, the Chair of the panel in consultation with the members, may limit the participation of a member in the meeting or ask him/her to make a verbal statement of affiliations and interests at the beginning of the meeting. Members' affiliations and interests are reviewed and updated as required, based on the changes in the status of their affiliations and interests.

In accordance with the Health Products and Food Branch Review of Health Canada Policy on External Advisory Bodies (2011), a person with a direct financial interest in the outcome of a review of a regulated product may be a member of an advisory body whose broader mandate encompasses matters of policy, management, or program development. However, such a member would not be asked to participate in any discussion, formulation of advice, or recommendations to Health Canada relating to that review.

Indicated [Sector/Perspective]

• Health professional
• Research
• Academia
• Patient representative

Indicated [Expertise/Experience]

• Chronic pain management
• Opioid abuse
• Pharmacology
• Addiction and prescription drug abuse
• Substance use disorder, harm reduction and overdose prevention

1) Direct financial interests

1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares or bonds, with the regulated industry.

2) Indirect financial interests

1. Within the past five years, payment from regulated industry for work done or being done, including past employment, contracts or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria.^{Footnote 1}
2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at meetings where all or part of the travel and accommodation costs were provided by the regulated industry.^{Footnote 2}
3. Within the last three years, grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision making.^{Footnote 3}

3) Intellectual interests

1. Within the last five years, any formal advice or opinion to industry, a government organization, or a non-government organization, on a matter of relevance to the SAP-Opioids mandate.
2. Within the past five years, any published or publicly stated point of view on issues of relevance to the SAP-Opioids mandate.
3. Current professional or volunteer affiliations such as membership of professional societies, lobbying, public interest or advocacy groups, of relevance to the SAP-Opioids mandate.

4) Other

1. Any other affiliations and interests or potential circumstances that might give a well informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation in the SAP-Opioids.